Open original FDA record ↗Recall record
- FDA identifier
- Z-2639-2014
- Company in FDA record
- Amerx Health Care Corp.
- FDA classification date
- Sep 12, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Not approved labeling claims (antimicrobial and autolytic debridement)
Source facts
- Action
- On July 21, 2014, Amerx Health Care Corporation telephoned all affected customers advising them of the recalled products. During the call the customers were instructed to: 1) Discontinue dispensing the lot(s) and promptly return via parcel post to the Clearwater facility. 2) If you dispose of the product on your own, provide proof of disposal. 3) You will be reimbursed by check or credit memo for returned or disposed goods and postage.
- Initiated
- 2014-07-11
- Root cause
- Labeling design
- Terminated
- 2015-07-22
- Distribution
- Worldwide Distribution-USA (nationwide) including the District of Columbia, Virgin Islands, Puerto Rico, and Guam, and the states of AK, AL, AZ, CA, CO, CT, FL, GA, HI, IL, IN, KS, KY, LA, MA, ME, MD, MI, MT, MO, NC, NH, NE, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WY, and WV, and the countries of Canada, England, Africa, and Australia.
- Recall number
- Z-2639-2014
- Recall status
- Terminated
- CDRH record ID
- 129597
- FDA classified
- 2014-09-12
- Recall event number
- 69083